Exhibit FILING FEES.
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Avenue Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
Security |
Fee |
Amount |
Proposed |
Maximum |
Fee Rate |
Amount of |
||||||||||||||
Equity |
Common Stock, par value $0.0001 per share |
Other |
5,000,000 |
$ |
3.335 |
(2) |
$ |
16,675,000 |
0.00014760 |
$ |
2,461.23 |
||||||||||
Total Offering Amounts |
$ |
16,675,000 |
$ |
2,461.23 |
|||||||||||||||||
Total Fee Offsets |
— |
||||||||||||||||||||
Net Fee Due |
$ |
2,461.23 |
(1) Pursuant to Rules 457(c) and 457(h) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is the average of the high and low prices reported for the registrant’s Common Stock quoted on The Nasdaq Capital Market LLC on July 5, 2024.
(2) Represents 5,000,000 additional shares reserved for issuance under the Avenue Therapeutics, Inc. 2015 Incentive Plan, as amended (the “Plan”). Pursuant to Rule 416(a) under the Securities Act, this registration statement also covers an indeterminate number of additional shares as may be necessary to account for adjustment provisions under the Plan as a result of stock splits, stock dividends or similar transactions.